Immune & longevity peptides
The peptides marketed for immunity, healthy ageing and “longevity” — the thymic peptides, the NAD⁺ supplements, the mitochondrial and senolytic compounds, and the Russian bioregulators — grouped by what they are, and marked for what the evidence actually is.
This is the thinnest-evidence corner of the field. A few thymic peptides are approved medicines; most of the rest are supplements or unapproved research chemicals whose anti-ageing claims rest on weak or single-group evidence. This is a factual map, not advice, and nothing here is medical advice.
What “longevity peptides” are
A loose family united by a promise — to slow ageing or boost immunity — more than by a shared mechanism. Some genuinely act on immune training (the thymic peptides) or cell metabolism (NAD⁺); others rest on striking but unreplicated claims. The grouping below is by what each compound is, with the evidence stage marked on every one.
Three ways in, side by side
A thymic peptide, a metabolic coenzyme and a bioregulator extract — three very different things.
| Thymosin alpha-1Thymalfasin, Zadaxin | NAD+NAD | EpithalamineEpithalamin, Epitalamin | |
|---|---|---|---|
| Type | Thymic immune peptide | Metabolic coenzyme | Pineal bioregulator extract |
| Evidence | Registered; clinical data | Early clinical; thin | Preclinical; single-group |
| Status | Approved | In trials | Experimental |
The full immune & longevity family
Every immunity- or ageing-marketed compound in the reference, grouped by type.
Thymic & immune peptides
Peptides from, or modelled on, the thymus — the gland that trains the immune system.
- Thymosin alpha-1 (Thymalfasin, Zadaxin) Approved Synthetic 28-amino-acid thymus peptide, registered in dozens of countries for chronic hepatitis B and C.
- Thymalin (Timalin, Thymalinum) Approved Bovine thymus extract from the Russian bioregulator programme, with mortality claims the evidence cannot carry.
- Thymogen (Timogen) Approved Synthetic thymic dipeptide registered in Russia; the same molecule failed Western cancer trials as oglufanide.
- Thymopentin (Timunox) Approved Synthetic pentapeptide fragment of thymopoietin, marketed as a prescription immunomodulator in several countries.
- Thymulin (FTS) Experimental Zinc-dependent nine-amino-acid thymic hormone; well-described physiology, almost no modern clinical research.
NAD⁺ & its precursors
The coenzyme at the centre of the longevity-supplement market, and the oral precursors sold to raise it.
- NAD+ (NAD) In trials Not a peptide but a coenzyme: central to energy metabolism, popular as an infusion on strikingly thin evidence.
- NMN In trials Not a peptide but a nucleotide: an oral NAD+ precursor that reliably raises NAD+ and reliably little else.
- Nicotinamide riboside (NR, Niagen) In trials Not a peptide but a vitamin B3 form: an oral NAD+ precursor, well studied, with modest clinical results.
Mitochondrial peptides
Peptides that act on the mitochondria — the cell’s power plants.
- SS-31 (elamipretide) (Elamipretide, Bendavia) Approved Mitochondria-targeted tetrapeptide binding cardiolipin; US-approved for Barth syndrome since 2025.
- Humanin (HN) Experimental Mitochondrially encoded 24-amino-acid peptide that inhibits cell death; studied as a marker, not a drug.
Anti-ageing & senolytic
The compounds aimed squarely at the biology of ageing — clearing senescent cells or shifting ageing-associated proteins.
- FOXO4-DRI (Proxofim) Experimental Experimental senolytic peptide from a 2017 mouse study, sold to consumers despite zero human safety data.
- GDF-11 Experimental TGF-beta family protein at the centre of an unresolved scientific dispute about whether it rejuvenates or harms tissue.
- Klotho (KL) Natural hormone A large longevity-associated membrane protein with strong biology and no consumer product that plausibly delivers it.
Antimicrobial & antioxidant
Immune-supporting proteins and an endogenous antioxidant sold as supplements.
- Lactoferrin (Lf, LTF) In trials An iron-binding milk protein sold as an oral supplement, with real randomised trial data and genuinely mixed results.
- Glutathione (GSH) In trials Not a peptide drug but an endogenous tripeptide: the principal intracellular antioxidant.
- VIP (vasoactive intestinal peptide) (Aviptadil, VIP) In trials Endogenous 28-amino-acid neuropeptide; intranasally known mainly from Shoemaker's CIRS protocol.
- PNC-27 Experimental Synthetic p53-HDM-2 fusion peptide that lyses cancer-cell membranes in the lab; no human trials, sold to patients.
Khavinson bioregulator extracts
Short peptides and tissue-extract capsules from the Russian bioregulator programme, marketed for organ-specific “regulation” on thin evidence.
- Epithalamine (Epithalamin, Epitalamin) Experimental Bovine pineal gland extract from the Khavinson programme and the source material from which Epitalon was derived.
- Endoluten Experimental Bovine pineal extract capsule from the Khavinson Cytomax line, with no published study under that name.
- Cerluten Experimental Bovine brain extract capsule from the Khavinson Cytomax line, with no published study under that name.
- Ventfort Experimental Calf blood-vessel extract capsule from the Khavinson Cytomax line, with no published study by that name.
- Vladonix Experimental Calf thymus extract capsule from the Khavinson Cytomax line; not the injectable Thymalin, and unstudied.
- Ovagen Experimental Khavinson bioregulator sold for liver support; the marketed product is a synthetic peptide, not a liver extract.
- Prostamax Experimental Khavinson synthetic tetrapeptide marketed for the prostate; chromatin claims from a single research group.
- Chonluten Experimental Khavinson tripeptide marketed as a lung and bronchial bioregulator, with essentially no clinical evidence.
Immune & longevity peptides: common questions
What is thymosin alpha-1 used for?
Do NAD⁺ infusions actually work for anti-ageing?
What is the difference between NAD⁺, NMN and NR?
Are the Khavinson bioregulator peptides (Epitalon, Thymalin) proven?
Are these longevity peptides legal and banned in sport?
Browse all immune & longevity entries · How to read the research · Legal status